Expressions and Significance of PTEN and LKB1 in Non-small Cell Lung Cancer

LI Yang, LI Ying, YANG Hui. et al

Abstract

To analyze the correlation between the expression of PTEN and LKB1 in non-small cell lung cancer (NSCLC). Methods Paraffin blocks of 74 cases of NSCLC patients were collected, and the expression of LKB1 and PTEN were detected by immunohistochemistry. The clinical related index and the correlation with the expression of PTEN and LKB1 were analyzed to explore the expression clinical significance of them. Results The PTEN and LKB1 expression positive rate were 47.3% and 70.3%, respectively. LKB1 expression negative samples were mostly associated with PTEN negative expression. Statistical analysis showed that LKB1 was positively correlated with PTEN expression ( r=0.287, P=0.017). The expression of PTEN and LKB1 in NSCLC had no relationship with gender, age and pathology type ( P>0.05). The expression of PTEN is closely associated with lymph node metastasis (LNM, P=0.017), invasion ( P=0.008) and clinical stage ( P=0.019). And lack expression of LKB1 was closely associated with tissue invasion ( P=0.043) and clinical stage ( P=0.003). Patients with PTEN and LKB1 positive showed more LNM and/or invasion than those with them negative. Conclusion The expression of PTEN and LKB1 may be related to the occurrence and progression of NSCLC, and may have a synergistic effect, and it can be used as a judgment of the prognosis of NSCLC.

 

Keywords: Non-small cell lung cancer, PTEN LKB1, Immunohistochemistry 

 

Full Text:

PDF


References


ETTINGER DS. WOOD DE. AKERLEY W. et al. Non-small cell lung cancer. Version 6. 2015. J Natl Compr Cane Netw,2015,13(5):515-524.

CHEN Z, FILLMORE CM, HAMMERMAN PS, et al. Non-small cell lung cancers; a heterogeneous set of diseases. Nat Rev Cancer,2014,14(8):535-546.

XU CX. FILLMORE CM, KOYAMA S, et al. Loss of LKB1 and PTEN leads to lung squamous cell carcinoma with Elevated PD-LI expression. Cancer Cell, 2014 , 25 ( 5 ): 590- 604.

MILELLA M, FALCONE I, CONCIATORI F, et al. PTEN; multiple functions in human malignant tumors. Front Oncol.2015(5);24 2016-01-12 . http://www. researchgate. net/publication/273466580_ PTEN_ Multiple_ Functions_ in_ Human_Malignant_Tumors. doi:10. 3389/fonc. 2015. 00024. PUCJ, KENIRY M, LI HS, et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell,2005,7(2): 193-204.

KIM I), KIM S, КОН H, et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J, 2001,15(11); 1953-1962.

FANG J, DING M, YANG L, et al. PI3K/PTEN/АКТ signaling regulates prostate tumor angiogenesis. Cell Signal. 2007.19(12):2487-2497.

LIU LZ, ZHOU XD, QIAN G, et al. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6Kl pathway. Cancer Res,2007,67(13);6325-6332.

PARSA AT, WALDRON JS, PANNER A, et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007, 13( 1 ): 84- 88.

JI H. RAMSEY MR, HAYES DN. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature, 2007, 448 (7155) :807-810.

REUNGWETWATTANA T, WEROHA SJ, MOLINA JR. Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small cell lung cancer (NSCLC). Clin Lung Cancer.2012.13(4):252-266.

MARCUS AI. ZHOU W. LKB1 regulated pathways in lung cancer invasion and metastasis. J Thorac Oncol,2010>5( 12) : 1883-1886.

ALESSIDR, SAKAMOTO K. BAYASCAS JR. LKB1- dependent signaling pathways. Annu Rev Biochem. 2006 (75);137-163.

ROY BC, KOHNO T, IWAKAWA R, et al. Involvement of lkbl in epithelial-mesenchymal transition ( EMT) of human lung cancer cells. Lung Cancer.2010.70(2): 136-145.

GAO Y, XIAO Q. MA H, et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A.2010,107(44): 18892- 18897.

HUANG X, WULLSCHLEGER S, SHPIRO N. et al. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J. 2008, 412 (2):211-221.

TAKEDA H, MIYOSHI H. KOJIMA Y. et al. Accelerated onsets of gastric hamartomas and hepatic adenomas/ carcinomas in Lkbl+/ — p53 — /— compound mutant mice. (bcogene, 2006,25 (12); 1816-1820.

MORTON JP. JAMIESON NB. KARIM SA. Et al. LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21 -dependent growth arrest. Gastroenterology,2010,139(2) :586-597.

SHORNING BY, GRIFFITHS D. CLARKE AR. LKB1 and PTP3N synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PLoS One,2011,6 (1): el6209[2016-01-12]. http;//dx. doi. org/10. 1371/journal, pone. 0016209.

CHENG H, LIU P, ZHANG F, et al. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkbl is highly responsive to mTOR inhibition. Cancer Res,2014 , 74( 1); 15-23.


Refbacks

  • There are currently no refbacks.